Therapeutic Asset Ratings
8,586 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
bay2927088
Advanced Non-small Cell Lung Cancer
Bayer
P1/2
BB
(65)
cc-5013
Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
National Health Research Institutes, Taiwan
P1/2
BB
(65)
Irinotecan
Recurrent Adult Soft Tissue Sarcoma
GI Innovation, Inc.
P1/2
BB
(65)
Larotrectinib
Solid Tumors Harboring NTRK Fusion
Bayer
P1/2
BB
(65)
Prizloncabtagene Autoleucel
Non-Hodgkin's B-cell Lymphoma
Janssen Research & Development, LLC
P1/2
BB
(64)
Carboplatin
Esophagogastric Cancer
Iambic Therapeutics, Inc
P1/2
B
(63)
cd22 car-transduced t cells
Lymphoma, B-Cell
Kecellitics Biotech Company Ltd
P1/2
B
(63)
Cediranib
Adult Solid Neoplasm
National Cancer Institute (NCI)
P1/2
B
(63)
Cyclophosphamide
Digestive System Neoplasms
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
B
(63)
Irinotecan
Adult Mixed Glioma
National Cancer Institute (NCI)
P1/2
B
(63)
Photofrin II
Non-Small Cell Lung Carcinoma
Roswell Park Cancer Institute
P1/2
B
(63)
Vinorelbine
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
P1/2
B
(63)
Carfilzomib
Stage III Adult Diffuse Large Cell Lymphoma
Pfizer
P1/2
B
(62)
Cediranib
Blastic Phase Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
P1/2
B
(62)
DEXAMETHASONE
Brain and Central Nervous System Tumors
Institut Curie
P1/2
B
(62)
Irinotecan
Adult Nasal Type Extranodal NK/T-cell Lymphoma
City of Hope Medical Center
P1/2
B
(62)
(+)-VINCRISTINE
Adult Mixed Glioma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
P1/2
B
(62)
ANTI-CD33 MONOCLONAL ANTIBODY BI 836858
Leukemia, Myeloid, Acute
Philogen S.p.A.
P1/2
B
(61)
Fludarabine
Digestive System Neoplasms
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
B
(61)
Irinotecan
Blastic Phase Chronic Myelogenous Leukemia
OHSU Knight Cancer Institute
P1/2
B
(61)
MIDAZOLAM
Advanced Cancer
PMV Pharmaceuticals, Inc
P1/2
B
(61)
Sorafenib
Refractory Malignancy
St. Jude Children's Research Hospital
P1/2
B
(61)
Avapritinib
CNS Tumor
Blueprint Medicines Corporation
P1/2
B
(60)
Capecitabine
Disseminated Tumor Cell
University of Southern California
P1/2
B
(60)
Carboplatin
High Grade Serous Ovarian
National Cancer Institute (NCI)
P1/2
B
(60)
Showing 1 to 25 of 8,586 assets
Previous
Page 1 of 344
Next